Study Finds GLP-1 Drug Semaglutide Linked to Lower Risk of Mental Health Issues

A recent study published in Lancet Psychiatry shows that Semaglutide, a GLP-1 drug used for weight loss, is associated with reduced risks of depression, anxiety, and self-harm. This finding suggests the drug’s benefits may extend beyond weight management to improving mental health outcomes. Researchers will need to conduct further trials to confirm these effects and understand the mechanisms involved.